Abstract| Volume 46, SUPPLEMENT 2, e43, January 2018

Evaluation of the therapeutic potential of Tangeritin against the symptoms of Parkinson’s disease

      Parkinson’s disease (PD) is a progressive neurodegenerative disorder. The disease is characterised by the loss of dopaminergic neurons leading to the major pathological hallmarks.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect